| Functional SARS-CoV-2-specific immune memory persists after mild COVID-19 LB Rodda, J Netland, L Shehata, KB Pruner, PA Morawski, CD Thouvenel, ... Cell 184 (1), 169-183. e17, 2021 | 711 | 2021 |
| Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template BD Sather, GS Romano Ibarra, K Sommer, G Curinga, M Hale, IF Khan, ... Science translational medicine 7 (307), 307ra156-307ra156, 2015 | 273 | 2015 |
| Engineering HIV-resistant, anti-HIV chimeric antigen receptor T cells M Hale, T Mesojednik, GSR Ibarra, J Sahni, A Bernard, K Sommer, ... Molecular therapy 25 (3), 570-579, 2017 | 184 | 2017 |
| Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity LB Rodda, PA Morawski, KB Pruner, ML Fahning, CA Howard, N Franko, ... Cell 185 (9), 1588-1601. e14, 2022 | 142 | 2022 |
| Engineering protein-secreting plasma cells by homology-directed repair in primary human B cells KL Hung, I Meitlis, M Hale, CY Chen, S Singh, SW Jackson, CH Miao, ... Molecular Therapy 26 (2), 456-467, 2018 | 109 | 2018 |
| Gene editing to induce FOXP3 expression in human CD4+ T cells leads to a stable regulatory phenotype and function Y Honaker, N Hubbard, Y Xiang, L Fisher, D Hagin, K Sommer, Y Song, ... Science translational medicine 12 (546), eaay6422, 2020 | 82 | 2020 |
| Obesity triggers enhanced MDSC accumulation in murine renal tumors via elevated local production of CCL2 M Hale, F Itani, CM Buchta, G Wald, M Bing, LA Norian PloS one 10 (3), e0118784, 2015 | 76 | 2015 |
| Homology-directed recombination for enhanced engineering of chimeric antigen receptor T cells M Hale, B Lee, Y Honaker, WH Leung, AE Grier, HM Jacobs, K Sommer, ... Molecular Therapy-Methods & Clinical Development 4, 192-203, 2017 | 71 | 2017 |
| The long and the short of it: insights into the cellular source of autoantibodies as revealed by B cell depletion therapy M Hale, DJ Rawlings, SW Jackson Current opinion in immunology 55, 81-88, 2018 | 47 | 2018 |
| The TYK2-P1104A Autoimmune Protective Variant Limits Coordinate Signals Required to Generate Specialized T Cell Subsets JA Gorman, C Hundhausen, M Kinsman, T Arkatkar, EJ Allenspach, ... Frontiers in immunology 10, 44, 2019 | 34 | 2019 |
| IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2 M Hale, J Netland, Y Chen, CD Thouvenel, KN Smith, LM Rich, ... Journal of Experimental Medicine 219 (9), e20220849, 2022 | 27 | 2022 |
| Efficient modification of the CCR5 locus in primary human T cells with megaTAL nuclease establishes HIV-1 resistance GSR Ibarra, B Paul, BD Sather, PM Younan, K Sommer, JP Kowalski, ... Molecular Therapy-Nucleic Acids 5, 2016 | 22 | 2016 |
| Electronic health records contain dispersed risk factor information that could be used to prevent breast and ovarian cancer TH Payne, LP Zhao, C Le, P Wilcox, T Yi, J Hinshaw, D Hussey, ... Journal of the American Medical Informatics Association 27 (9), 1443-1449, 2020 | 12 | 2020 |
| Effective, safe, and sustained correction of murine XLA using a UCOE-BTK promoter-based lentiviral vector BJ Seymour, S Singh, HM Certo, K Sommer, BD Sather, S Khim, ... Molecular Therapy-Methods & Clinical Development 20, 635-651, 2021 | 11 | 2021 |
| Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template. Sci Transl Med 7: 307ra156 BD Sather, GS Romano Ibarra, K Sommer, G Curinga, M Hale, IF Khan, ... | 5 | 2015 |
| Dynamics of SARS-CoV-2 VOC neutralization and novel mAb reveal protection against Omicron L Hao, TY Hsiang, RR Dalmat, R Ireton, JF Morton, C Stokes, J Netland, ... Viruses 15 (2), 530, 2023 | 4 | 2023 |
| 238. BTK-Promoter LV Vectors Utilizing Conserved Intron Element Mediate Functional Rescue in Murine XLA S Singh, B Seymour, K Sommer, I Khan, S Khim, M Hale, C Clough, ... Molecular Therapy 23, S93, 2015 | 4 | 2015 |
| 284. High-Efficiency Targeted Introduction of an Anti-CD19 CAR Into the CCR5 Locus in Primary Human T Cells M Hale, GSR Ibarra, IF Khan, J Sahni, AM Scharenberg, DJ Rawlings Molecular Therapy 23, S113-S114, 2015 | 2 | 2015 |
| 761. Targeted Killing of HIV Infected Cells Using CCR5-Disrupted Anti-HIV-CAR T Cells GSR Ibarra, M Hale, K Sommer, I Khan, J Sahni, C Peterson, HP Kiem, ... Molecular Therapy 24, S301, 2016 | 1 | 2016 |
| 116. MegaTAL nucleases outperform TALENs in promoting homology-directed-gene modification in primary human T cells G Curinga, G Romano, B Sather, K Sommer, M Hale, I Khan, S Singh, ... Molecular Therapy 23, S48, 2015 | 1 | 2015 |
